Letters to shareholders on annual report weblink whose email ids are not registered with the company/RTA

o SANDU PHARMACEUTICALS LIMITED CIN:L24233GA1985PLC001587 SAMDU w Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511. Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in Ref : Corp.sec/2026-27/BSE/477 Department of Corporate Services Bombay Stock Exchange Limited, Phirojshah Jeejobhoy tower, Dalal Street, Mumbai-400001 Date:19/08/2026 Sub: Letter to shareholder on Annual Report — Weblink R crip Code : 524703 The 41% AGM of the Company is scheduled to be held on Friday, the 11" September 2026 at 4.30 PM through Video Conference / Other Audio Visual Means (VC/ OAVM) to transact the businesses set out in the Notice for the 41°' AGM. In compliance with relevant MCA and SEBI circulars, Notice of AGM and the Annual Report for FY 2026-27 are being sent only by electronic mode to shareholders whose email address is registered either with the Depository Participants (DP) or the Company/Registrar & Transfer Agent (RTA). In compliance with Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015, letter (copy enclosed) providing the web-link, including the exact path, where complete details of the Annual Report for FY 2026-27 of the company is available is being sent to those Shareholders who have not registered their email address with the Depository Participants (DP) or the Company/Registrar & Transfer Agent (RTA). The Annual Report for FY 2026-27 is available on the path Investors > Annual Reports> FY 2026-27 at https://sandu. ‘annual-report-2 A copy of the letter sent to the concerned shareholders is enclosed herewith for your records. Yours Faithfully, FOR SANDU PHARMACEUTICALS LIMITED. Pratika Mhambray Company Secretary ACS:36512 Encl: - As Above AN ISO 9001:2015 CERTIFIED ORGANISATION R Corporate Office: P B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai - 400 071. (7 \% Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in H "-;m\% FRYE UF B INLAND LETTER CARD Sr No.: 3333/ XXXXXXXXXXXX4894 DMYANTI PATEL HOUSE NO 2 SHARDA ESTATE VAZIRA NAKA L. T ROAD BORIVALI WEST MUMBAI 400092 MUFG Intime India Private Limited (Fommerly Link Intime India Private Linited) A part of MUFG Corporale Markets, a division of MUFG Pension & Market sarvices Unit: Sandu Pharmaceuticals Limited C-101, Embassy 247, LBS Marg, Vikhroli (W), Mumbai - 400083 Jua). Intime -fl‘-’ SANDU PHARMACEUTICALS LIMITED SANDU CIN:L24233GA1983PLC001587 m Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511. Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in Dear Shareholder, Sub: Notice of 41"Annual Genera| Meeting (AGM) of Sandu Pharmaceuticals Lit Anj for the Financial Year 2025:26. We are pleased to inform you that the 41* Annual General Meeting (AGM') of the Members of Sandu Pharmaceuticals Limited is scheduled to be held on Friday, September 11, 2026, at 04:30 P.M. {IST) through Video Conferencing (VC') facility /Other. Audio Visual Means ('CAVM'). As per Regulation 36 (1) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (SEBI Listing rR ee qg uu il ra et di o tn os b, e 2 s0 e15 n' t) t, o a ts h oa sm ee mn ede md b, et rhe ( w wse hb )o-l hi ank v, e i nn oc tl rud ei gn ig s tt eh re e de tx ha ec it r p ea mt ah i, l w adh de rr ee s sc (o em sp )l se it te h ed re t wa ii tl hs t hof e Cth oe m A pn an nua yl o rR e wip lo lr it a na yr De ea pva oi sl iab tl oe r oi ys r with Registrar & Share Transfer Agent (RTA) of the Company i.e. MUFG Intime India Private Limited (Formerly Link Intime India Private Limited). Accordingly, the webink, including the exact path where complete details of the Annual Report for the Financial Year 2025-26 are available at: Weblink: hiips:/isandu.in/ = k) o : g {3 Annuai Report | isifsandu infannual-repont-2/ E!.,*‘_ 4 202526 This letter is being sent to those members wha have not registered their emil address(es) either with the Company or with any tD he ep o es ai rft io er sy t wo ir t R h T yA ou o rf dt eh pe o sC io tm orp ya pn ay rt a ics i o pan n tt sh e ( oc eut t-o af lf l d ia nt pe or a ts a no tn i n0 f7 o. r0 m8 a. t2 i0 o2 n6 . & F du or ct uhe mr e, n y to su t ha er re e r afe tq eu re as nte dd e t no c oup ud ra al gt ee y Go ru er e e nm Ia ni il ti aa td ivd er .e ss at This communicalion is also a reminder to the Shareholders to update their KYC details pursuant to SEB! Master Circular No. HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 dated 6" February 2026, and to demalerialise physical securities. The circular issued by S SEB iI m gan nd oa f t ase es ctu ra ill tu yt hh roe l dl eei rs ste d h oc lo dim np ga n si ece us ri tt io e sr e inc o pr hd y sP icA aN l, m A od dd er .e Ws hs i lw ei t uh p dP aI tN i nc go ed me a, i lM io cb i isl e o pN tiu om nb ale ,r t, h eB sa en ck ur A ilc yc o hou ln dt e rd se t aa ri el s r, e qS up ee sc ti em de tn o register emailid also to avail onling services. This is applicable for all security holders holding securitieisn physical made. The formats for choice of nomination and updation of KYC details viz; Forms ISR-1, ISR-2, ISR-3, SH-13, SH-14 and SEBI circulars are available on RTA's website as mentioned below: https:#in.mpms.mufg.com/> Resources > Downloads > KYC > Formatfosr KYC. The aforesaid SEBI Circular alsa mandates that security holders holding securities in physical mode and whosa folios) do not have PAN, contact details, bank account details and specimen signature updated, shall be eligible for any payment including dividend, interest orredemption paymentin respectof such folios, only through electronic mode with effectfrom 17 April 2024. In case of any query, please feel free to contact our RTA i.e. MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) on the details provided below: Morsavar, you are also requested to support the green initiative of the Company aimed at having paperless communication with s slakeholders by updating your email address at the earliest either tarough your depository partifocr sihaprehaolnditng in electronic form or send a communication to the Company or its RTAin caof pshysiecal shareholdintgo facilitate the updation of email ic, which will enable the Shareholder to continue to receive all importantinformation& documents thereafter by email. MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) Address: C-101, Embassy 247, LBS Marg, Vikhroli (West), Mumbai -400083, Tel No-+91 8108116767 email.investor.helpdesk@in.mpms.mufg.com Thank you, Yours taithfully, For Sandu Pharmaceuticals Limited Sdi- Pratika Mhambray Company Secretary & Compliance Officer A:36512 : AN (SO 9001:2015 CERTIRED ORGANISATION @Igl' Corporate Office: P: B. No. 17201, Sandu Nagas, D. K. Sandiu Marg, Chembur, Mombai - 400 071, @ Tel: +91 22 2528 4402 / 3306, E-mai: info@sanduiin